Lamotrigine Tablet, Extended Release
Product Images NDC 13668-340

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 13668-340). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Clinicalstudy1 Partialonsetseizure

This is a statistical graph that shows the responder rates of patients who took Lamotrigine Extended-Release Tablets compared to a placebo. The vertical axis measures improvement or worsening in percentages, ranging from -50% to 75%. The horizontal axis shows the percentage of patients who experienced improvement or worsening. The graph also displays two data points, one at 75% improvement for Lamotrigine and one at -100% worsening for the placebo group. The remaining text is too fragmented to provide a clear description.*

FDA Label Image

Image Clinicalstudy2 Partialonsetseizure

FDA Label Image

Label 100mg

This is a medication cautioning the user to verify the product before use. Each film-coated tablet contains 100mg of lamotrigine, USP. The medication should be stored between 20°C to 25°C, with excursions permitted to 15°C to 30°C. It should be dispensed in a tight container with a child-resistant closure. The usual dosage is provided in the accompanying prescribing information. The medication is manufactured in India by Torrent Pharmaceuticals LTD and is distributed in the USA by Torrent Pharma INC. Each packet contains 30 extended-release tablets. The NDC number for the medication is 13668-341-30.*

FDA Label Image

Label 200mg

This text describes a caution to verify the dispensed product, which is a bottle of 30 tablets with NDC code 13668-342-30, each containing 200mg of lamotrigine. The tablets are film-coated and should be stored at controlled room temperatures, and dispensed in a tight container. The recommended dosage information is found in the accompanying prescribing information. The manufacturer is Torrent Pharmaceuticals Ltd. with licensing number 6/926, and the product is manufactured for Torrent Pharma Inc. in Levitown, PA with the brand name Femara RX ORI.*

FDA Label Image

Label 25mg

The text is a product label for Lamotrigine extended-release tablets. The tablets come in a tight container with child-resistant closure and each contains 25 mg of Lamotrigine, USP. The recommended storage temperature is between 20° to 25°C (68° to 77°F), with permissible excursions to 15° to 30°C (59° to 86°F). The product information advises to dispense the medicine to patients with an accompanying prescribing and medication guide. The product is manufactured by Torrent Pharmaceuticals LTD, India and packaged for Torrent PharmaInc, Levitiown, PA 19057.*

FDA Label Image

Label 50mg

This is a cautionary label found on a bottle containing 30 tablets of lamotrigine, each coated with a film and containing 50mg of the compound. The medicine should be stored at temperatures between 20°C to 25°C, with permitted excursions to 15°C to 30°C. It should be dispensed in a tightly sealed container along with its accompanying medication, with the usual dosage as prescribed in the accompanying prescribing information. The bottle was manufactured by Torret FamaceutitionsLTD, and the product is distributed by Torrent Pharnia Inc.*

FDA Label Image

Logo mg

FDA Label Image

Logo Pi

FDA Label Image

Structure

FDA Label Image

Tabletsappearence

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.